
Industrial & Financial Services · NSE / BSE
Founded in 2007, Jupiter Life Line Hospitals Limited is a leading multi-specialty healthcare provider in the Mumbai Metropolitan Region (MMR) and western India. Operating under the "Jupiter" brand, the company runs three hospitals in Thane, Pune, and Indore, with a total of 1,194 beds and a team of 1,306 doctors, including specialists, physicians, and surgeons (as of March 31, 2023). A new multi-specialty hospital is also under development in Dombivli, Maharashtra, with plans for over 500 beds. Construction began in April 2023. Jupiter Life Line Hospitals stands out for its advanced neuro-rehabilitation services in Thane and Indore, featuring robotic and computer-assisted treatments, as highlighted in the CRISIL Report. It also operates one of the few multi-organ transplant centers in Thane. All its hospitals are NABH-certified and NABL-accredited for medical testing. In Fiscal 2023, revenue from inpatient and outpatient services was distributed across its hospitals: Thane (54.18%), Pune (34.03%), and Indore (11.79%).
Price Band
₹695 – ₹735
Issue Size
₹869 Cr
Lot Size
20 shares
GMP
+33.5%
Est. Listing
₹981
at current GMP
Subscribed
63.72x
overall
Open
6 Sep 2023
Close
8 Sep 2023
Allotment
13 Sep 2023
Refund
14 Sep 2023
Demat Credit
15 Sep 2023
Listing
18 Sep 2023
Overall Subscription
63.72x
Total Demand
QIB Multiplier
187.32x
Institutions & Funds
NII / HNI
34.75x
High Net-Worth
Retail (RII)
7.73x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 2,372,880 | 444,494,800 | 187.32x |
| NIB | 1,837,287 | 63,846,320 | 34.75x |
| HNIs(10L +) | 1,224,858 | 48,057,860 | 39.24x |
| HNIs (2-10L) | 612,429 | 15,788,460 | 25.78x |
| RETAIL | 4,287,002 | 33,118,980 | 7.73x |
| Total | 10,334,456 | 605,306,420 | 63.72x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 206,924 | 1,599,523 | 7.73x |
| HNIs (10L +) | 1,324 | 46,009 | 34.75x |
| HNIs (2-10L) | 6,334 | 220,107 | 34.75x |
| Total Applications | 214,582 | 1,865,639 | 8.69x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Jupiter Life Line Hospitals Limited is bringing an initial public offering (IPO) in the Industrial & Financial Services sector with an aggregate issue size of ₹869.08 Crores. The shares are offered at a price band of ₹695 to ₹735 per equity share on NSE and BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 20 shares (approx. ₹14,700 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2023-09-15, while un-allotted funds or UPI block mandates will be released on 2023-09-14.
The latest Grey Market Premium (GMP) for Jupiter Life Line Hospitals Limited IPO is ₹246 per equity share. Based on the upper price band of ₹695 to ₹735 per equity share, the estimated listing price is ₹981 (+33.5% expected listing gain).
With a lot size of 20 shares and current GMP of ₹246, the expected profit per application lot is approx ₹4,920 (+33.5% gain). Minimum application cost is approx ₹14,700.
The Jupiter Life Line Hospitals Limited IPO aggregate issue size is ₹869.08 Crores with an equity price band set at ₹695 to ₹735 per equity share. The retail lot size is 20 shares requiring a minimum capital outlay of approx. ₹14,700.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 63.72x (Retail: 7.73x, QIB: 187.32x, NII: 34.75x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2023-09-13. Investors can verify status using PAN card or application number.
Jupiter Life Line Hospitals Limited shares are scheduled to list on NSE and BSE on 2023-09-18.